$TRAX 4 SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Orwin John A, Director Received 1,300 shares by exercise or conversion
04 Sep 2026	Form 4: Ware J. Anthony, Director Received 39,265 shares by exercise or conversion ($225K) · Sold 39,265 shares ($1.76M)
18 Aug 2026	Form 4: Stone Benjamin, Chief Business Officer Granted 60,492 Performance Stock Units
18 Aug 2026	Form 4: Lizzul Paul F., Chief Medical Officer Granted 60,492 Performance Stock Units
18 Aug 2026	Form 4: Faga Daniel, Director Granted 193,575 Performance Stock Units
05 Aug 2026	Form 4: Stone Benjamin, Chief Business Officer Granted 60,492 Performance Stock Units
05 Aug 2026	Form 4: Lizzul Paul F., Chief Medical Officer Granted 60,492 Performance Stock Units
05 Aug 2026	Form 4: Faga Daniel, Director Granted 193,576 Performance Stock Units
17 Jun 2026	Form 4: Jain Rita, Director Received 7,330 shares by exercise or conversion
17 Jun 2026	Form 4: Schmid John P., Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Orwin John A, Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Ware J. Anthony, Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Marquet Magda, Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Fenton Dennis M, Director Received 6,030 shares by exercise or conversion
14 May 2026	Form 4: Orwin John A, Director Granted 15,000 Restricted Stock Unit · Granted 42,000 Stock Option (right to buy)
14 May 2026	Form 4: Fenton Dennis M, Director Granted 15,000 Restricted Stock Unit · Granted 42,000 Stock Option (right to buy)
14 May 2026	Form 4: Stone Benjamin, Chief Business Officer Granted 26,700 Restricted Stock Unit · Granted 72,300 Employee Stock Option (right to buy)
14 May 2026	Form 4: Faga Daniel, Director Granted 100,200 Restricted Stock Unit · Granted 271,100 Employee Stock Option (right to buy)
14 May 2026	Form 4: Tamboli Ajim, Chief Financial Officer Granted 5,000 Restricted Stock Unit · Granted 13,600 Employee Stock Option (right to buy)
14 May 2026	Form 4: Lizzul Paul F., Chief Medical Officer Granted 26,700 Restricted Stock Unit · Granted 72,300 Employee Stock Option (right to buy)

Comments